JUSTIN GRANVILLE DONLAN
Allopathic & Osteopathic Physicians|Internal Medicine BEVERLY HILLS, CA NPI 1801328604
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine CA ViiV Healthcare Company All categories
General Payments — all program years on this page
$45,832.84
- Category: General Payments
- Program years: PY2021–2024
- Record count: 152
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $5,057.58 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,757.58 | 66 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,300.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ViiV Healthcare Company | $1,938.20 | 18 |
| Lumenis BE inc | $1,935.64 | 1 |
| Galderma Laboratories, L.P. | $446.02 | 3 |
| Gilead Sciences, Inc. | $251.34 | 24 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $135.13 | 6 |
| Daiichi Sankyo Inc. | $118.37 | 5 |
| Amgen Inc. | $64.30 | 3 |
| Merck Sharp & Dohme Corporation | $60.53 | 2 |
| EMD Serono, Inc. | $28.66 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.73 | 1 |
| Alnylam Pharmaceuticals Inc. | $22.41 | 1 |
| PFIZER INC. | $19.37 | 1 |
| Exact Sciences Corporation | $13.88 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.